Glucagon-Like Peptide-1 Receptor Agonist Treatment Patterns Among Type 2 Diabetes Patients in Six European Countries
Victoria Divino(Health Outcomes Solutions (United States)), Matthew Reaney(Sanofi (United Kingdom)), N. Varol(Eli Lilly (United States)), Shawn Hallinan(IQVIA (United States)), Won Chan Lee(IQVIA (United States)), Sara Bruce Wirta(Novartis (Switzerland)), Mitch DeKoven(IQVIA (United States))
Cited by 41
Related Papers
Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate‐to‐severe atopic dermatitis
|British Journal of Dermatology|2019|384
Evaluating patient-perceived control of atopic dermatitis: design, validation, and scoring of the Atopic Dermatitis Control Tool (ADCT)
|Current Medical Research and Opinion|2019|138
Development of Sinonasal Outcome Test (SNOT‐22) Domains in Chronic Rhinosinusitis With Nasal Polyps
|The Laryngoscope|2021|96
Real-World Treatment Patterns of Sacubitril/Valsartan: A Longitudinal Cohort Study in Germany
|European Journal of Heart Failure|2019|66
Burden of heart failure on caregivers in China: results from a cross-sectional survey
|Drug Design Development and Therapy|2018|48